BENITEC BIOPHARMA INC. (BNTC) Total liabilities 2019–2024
BENITEC BIOPHARMA INC. (BNTC) total liabilities at each fiscal year-end, per SEC filings.
$5.0MFY2024 · since FY2019: $2.6M → $5.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $5.0M | +16.4% |
| FY2023 | $4.3M | +37.9% |
| FY2022 | $3.1M | +125.8% |
| FY2021 | $1.4M | +1.5% |
| FY2020 | $1.3M | -48.9% |
| FY2019 | $2.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BNTC financial trends
BNTC RevenueBNTC Net incomeBNTC Net marginBNTC Gross profitBNTC Gross marginBNTC Operating incomeBNTC Operating marginBNTC Operating cash flowBNTC Free cash flowBNTC Capital expendituresBNTC Return on equityBNTC Stock buybacksBNTC Dividends paidBNTC Total assetsBNTC Shareholders’ equityBNTC overview →